In light of the fiscal plan proposed by US President Donald Trump, which includes cuts in public spending and tax reductions, Marcelo Ebrard , head of the Ministry of Economy (SE) , stressed that Mexico has logistical and competitive advantages in the face of the possible entry of products from other countries into the United States.

“Mexico has a number of very important advantages in this regard, enabling us to be competitive due to our productivity, our proximity, and a number of significant logistical advantages,” the federal official stated at Thursday’s morning press conference.

It is worth remembering that in March 2025 alone, total cross-border cargo between the United States and its North American partners reached a value of  144.8 billion dollars (mdd) , which represented an increase of 8.4% compared to the same month last year, according to data from the Bureau of Transportation Statistics (BTS) .

Of that figure,  $77.3 billion corresponded to trade with Mexico, which grew  13%  compared to March 2024.

At the event, Marcelo Ebrard ruled out the possibility that Mexico could be affected by the tax strategy promoted by Trump, although he indicated that “we are entering a system of comparative disadvantages. This means that each country will have to pay a different price to enter the United States market, and if you look at the agreement reached with Vietnam, Mexico will have a six-to-one advantage in the cost of entry into the United States.”

He explained that Trump’s tax package could allow imports of products from Vietnam, a competitor of Mexico, at higher costs.

He clarified that this means that “for Vietnamese products, entering the United States market will cost an average of between 35 and 40 percent, while it will cost us an average of 6 percent.”

“You can see that there’s a big disadvantage. So, it seems to me that this system that’s beginning to take shape will also have to wait and see how it ends. But I’m using yesterday’s agreement as a basis, because it’s the first agreement signed with a country with which the United States has a deficit,” Ebrard emphasized.

Mexico is a very competitive country in its manufacturing sector, he reiterated, and emphasized that “the bottom line is that our advantage will increase, which is why I don’t think the fiscal package will affect us.”

Trump’s tax plan includes, among other measures, more agents, detention centers, and surveillance technology, including Artificial Intelligence (AI). It also sets a $1,000 fee for asylum applications and reduces the tax on cash remittances from 3.5% to 1%. Some American analysts have suggested that it will ultimately indebt the United States and penalize migrants.

Ebrard’s statements came as four pharmaceutical companies announced a total of 10.48 billion pesos in investments as part of Plan Mexico.

“These four companies are examples of the investments we seek to expand our capabilities to foster research, innovation, and the development of advanced biotechnology in Mexico,” emphasized David Kershenobich, head of the Ministry of Health .

Comment and follow us on X:  @GrupoT21

El cargo Mexico has logistical and productive advantages over the US fiscal plan: Ebrard apareció primero en T21.

DHL Supply Chain Mexico announced that it has joined forces with pharmaceutical company Adium to redefine supply chain standards in the healthcare sector by establishing an innovative, precise logistics operation tailored to the needs of the market in the region.

According to information shared by the German company, this collaboration seeks to challenge and deliver quality-of-service health products to millions of patients.

“I am deeply pleased to be a business partner of a prestigious company like DHL Supply Chain, with world-class processes, capabilities and skills that underpin our expansion and growth plans at Adium. This alliance gives us the certainty of having the right partner to implement our ambitious expansion expectations, strengthening our commitment to innovation and service to our patients,” said José Miguel Fonken, CEO of Adium Mexico.

The operation is located in a 2,415 square meter (m2) distribution center in Mexico , and has specialized temperature-controlled warehouses that maintain the integrity of delicate products.

With capacity for 3,168 pallets in temperatures below 25 °C and 60 additional positions in conditions of 2-8 °C , this distribution center ensures that each medicine reaches its destination in optimal conditions.

DHL Supply Chain will be contributing its experience in logistics innovation, revolutionizing every aspect of the process, from storage to final delivery, offering advanced warehousing solutions , inventory control through the FEFO system, which gives priority to those medicines with a closer expiration date, and a product assembly and labeling process that maintains the highest quality standards in the industry.

The alliance between Adium and DHL Supply Chain Mexico is not only based on infrastructure, but on cutting-edge technology that connects both operating systems (Adium’s QAD and DHL’s BlueYonder) through nine interfaces that synchronize each transaction in real time.

This innovation enables absolute inventory visibility and operational efficiency that lays the foundation for the success of this supply chain.

“Nothing makes us more proud at DHL Supply Chain Mexico than being called partners. For us, that word represents a strategic and deep relationship, in which we work together to achieve common goals and grow as organizations. Our task is clear: to provide Adium with all the necessary tools to continue its impressive growth. It is a privilege to be part of this journey with Adium, and our commitment is to continue growing together,” said Mario Rodríguez, president of DHL Supply Chain Mexico.

DHL Supply Chain Mexico is promoting this collaboration with a range of logistics solutions that include temperature-controlled storage services and a high-precision inventory and distribution system.

Each stage, optimized with technology, allows Adium to respond quickly to demand, ensuring that each treatment arrives on time and in optimal conditions, thus raising the standard of pharmaceutical logistics in the region.

Comment and follow us on X: @GrupoT21

El cargo Adium and DHL Supply Chain boost pharmaceutical industry in Mexico apareció primero en T21.

The pharmaceutical industry faces various challenges , where supply chain optimization and the adoption of digital technologies emerge as essential pillars to face current and future challenges, according to the Global Pharmaceutical Supply Chain Study 2024 by Miebach Consulting.

According to the document shared by the consulting firm, after years of accumulating inventory “just in case” due to the pandemic , adapting and modernizing logistics processes will be crucial to ensure robust resilience and effective cost management.

Additionally, the global medicines industry is projected for significant expansion, with spending reaching $1.9 billion by 2027. This growth does not include COVID-19 vaccines or therapeutic spending.

The key factors driving this growth are the introduction of innovative products, patent expirations, and the rise of biosimilars.

The study predicts that Latin America, Asia Pacific, Africa and the Middle East will experience volume growth of more than 10% and a notable increase in spending, linked to population-driven expansion and the use of higher-cost products.

One of the most important approaches, currently, to improve supply chains is the optimization of processes and organizational changes, also highlighting :

• Inventory and Network Optimization Regular network optimization with comprehensive studies has become a top priority, displacing the traditional focus on mere cost reduction. This change responds to the need to increase resilience in the face of unexpected disruptions such as the COVID-19 pandemic and other geopolitical events.
• Visibility and collaboration Visibility throughout the supply chain, facilitated by the integration of global control towers, and genuine collaboration with logistics partners, are essential for effective planning and continuous operation. Collaborative forecasting and integrated business planning are key tools to achieve these goals.
• Automation and technology: The automation of logistics processes and the use of artificial intelligence (AI) and big data are fundamental technologies to improve efficiency and resilience. Adopting AI-based modules for network planning and optimization can offer a significant competitive advantage.

Furthermore, the study also highlights that although the pharmaceutical industry is a step behind others in implementing advanced solutions, it is beginning to adopt automation , collaborative partnerships and supply chain planning with approaches such as sales planning and operations (S&OP) and integrated business planning (IBP).

The analysis explains that, in the last decade, just as the priority has shifted from cost reduction to supply chain optimization , visibility remains crucial, but IT systems integration and collaboration with logistics providers are important challenges . Overcoming them requires genuine collaboration with partners, which can significantly strengthen the supply chain.

Likewise, among the proposed solutions are:

• Materials handling automation: Implement automated solutions for materials handling and internal transportation, as well as the optimization and bidding of transportation services.
• Inventory management, centralization of inventories on a regional and global scale, along with multi-level optimization, are recommended strategies to improve efficiency.
• Collaboration with suppliers, strengthening relationships with logistics providers, to ensure an uninterrupted production flow.

In that sense, automation and 24/7 operations are becoming a necessity, driven by labor shortages and competition in metropolitan areas.

The survey revealed that although data management has improved, inventory optimization remains essential to reduce costs and improve efficiency.

The global pharmaceutical industry study was carried out from November 2023 to January 2024 and used an online survey questionnaire, which was published globally on internet portals, social networks and in the press, where there were more than 300 participants of all the world.

The majority of participants come from supply chain and logistics roles , with a notable 10% in purchasing and 6% in executive positions, ensuring an accurate representation of the current state of supply chains, encompassing their evolution, challenges and future  trends.

Comment and follow us on X: @karinaquintero / @GrupoT21

El cargo These are the challenges facing the pharmaceutical supply chain apareció primero en T21.